US EditionPublished • loading... • Updated
United Therapeutics (NASDAQ:UTHR) CFO James Edgemond Sells 10,000 Shares
The sale generated $4.7 million and followed similar insider transactions by CEO Martine Rothblatt and CFO James Edgemond, all under Rule 10b5-1 plans.
Summary
1 Articles
1 Articles
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares of Stock
United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $581.63, for a total value of $5,525,485.00. Following the completion of the sale, the chief executive officer directly owned 40,513 shares of the company’s stock, valued at approximately $23,563,576.19. This represents a 19.00% decrease in thei…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
